Nicola Pimpinelli

Author PubWeight™ 65.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 WHO-EORTC classification for cutaneous lymphomas. Blood 2005 12.14
2 Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007 4.36
3 Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 2011 1.85
4 European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood 2008 1.73
5 Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 2006 1.70
6 EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood 2011 1.64
7 WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 2005 1.51
8 EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. Eur J Cancer 2006 1.38
9 TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007 1.35
10 Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells. Stem Cells 2012 1.26
11 Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 2008 1.20
12 Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol 2004 1.16
13 Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003 1.15
14 New and established topical corticosteroids in dermatology: clinical pharmacology and therapeutic use. Am J Clin Dermatol 2002 1.11
15 Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response. Biol Blood Marrow Transplant 2009 1.07
16 Skin cancer and immunosuppression. Crit Rev Oncol Hematol 2005 1.04
17 Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy. Clin Exp Metastasis 2012 0.97
18 Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors. Clin Cancer Res 2010 0.96
19 Spectral morphological analysis of skin lesions with a polarization multispectral dermoscope. Opt Express 2013 0.96
20 Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. J Invest Dermatol 2008 0.94
21 Massive recruitment of type I interferon producing plasmacytoid dendritic cells in varicella skin lesions. J Invest Dermatol 2006 0.94
22 Expression of Notch-1 and alteration of the E-cadherin/beta-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma). Mod Pathol 2009 0.92
23 A key role for poly(ADP-ribose) polymerase-1 activity during human dendritic cell maturation. J Immunol 2007 0.92
24 Lamina propria dendritic cells express activation markers and contact lymphocytes in chronic periodontitis. J Periodontol 2002 0.91
25 Primary cutaneous B-cell lymphomas. Current concepts. I. Haematologica 2004 0.91
26 Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment. J Infect 2012 0.89
27 Induction of CD83+CD14+ nondendritic antigen-presenting cells by exposure of monocytes to IFN-alpha. J Immunol 2008 0.89
28 Plasmacytoid dendritic cells represent a major dendritic cell subset in sentinel lymph nodes of melanoma patients and accumulate in metastatic nodes. Clin Immunol 2007 0.88
29 Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients. Cancer 2005 0.88
30 Role of conventional treatments on circulating and monocyte-derived dendritic cells in colorectal cancer. Clin Immunol 2006 0.87
31 Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. Cancer 2012 0.87
32 Pegylated liposomal doxorubicin in the treatment of primary cutaneous T-cell lymphomas. Haematologica 2007 0.86
33 Relationship between Latitude and Melanoma in Italy. ISRN Oncol 2012 0.82
34 Surgical management of suspicious melanocytic lesions in Italy. Dermatology 2013 0.82
35 Role of bexarotene in the treatment of cutaneous T-cell lymphoma: the clinical and immunological sides. Immunotherapy 2013 0.81
36 Photoexposition discriminates Notch 1 expression in human cutaneous squamous cell carcinoma. Mod Pathol 2008 0.81
37 Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin. Hum Pathol 2003 0.81
38 Indoleamine 2,3-dioxygenase+ cells correspond to the BDCA2+ plasmacytoid dendritic cells in human melanoma sentinel nodes. J Invest Dermatol 2009 0.81
39 Chronic hepatitis C virus hepatitis and psoriasis: no longer a contraindication to interferon use in the era of biological agents? Scand J Infect Dis 2012 0.81
40 Human Langerhans cells are immature in melanoma sentinel lymph nodes. Blood 2012 0.80
41 Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies. Eur J Haematol 2009 0.80
42 Primary cutaneous lymphomas: a reprisal. Semin Diagn Pathol 2011 0.79
43 Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme. Oncotarget 2014 0.79
44 Monochromatic excimer light (308 nm) in patch-stage IA mycosis fungoides. J Am Acad Dermatol 2004 0.79
45 Stem cell factor affects tumour progression markers in metastatic melanoma cells. Clin Exp Metastasis 2006 0.79
46 Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy. Histopathology 2011 0.78
47 Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon. J Chemother 2013 0.78
48 Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas. Eur J Haematol 2014 0.77
49 Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells. J Mol Med (Berl) 2015 0.77
50 Acute leucocytoclastic vasculitis and aquagenic pruritus long preceding polycythemia rubra vera. Eur J Dermatol 2002 0.77
51 Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study. J Am Acad Dermatol 2006 0.76
52 Contacts between mast cells and dendritic cells in the human skin. Ital J Anat Embryol 2010 0.76
53 Combined fluorescence-Raman spectroscopic setup for the diagnosis of melanocytic lesions. J Biophotonics 2013 0.76
54 Laser surgery in rhinophyma. G Ital Dermatol Venereol 2014 0.75
55 Atypical CD30+ cutaneous lymphoid proliferation in a patient with tuberculosis infection. Am J Dermatopathol 2004 0.75
56 Body image and awareness in patients with advanced-stage melanoma. G Ital Dermatol Venereol 2015 0.75
57 Diagnostic services for melanoma in Italy. Dermatology 2013 0.75
58 [Solar ultraviolet radiation risk in outdoor workers: a specific project of Tuscany Region (Italy)]. Epidemiol Prev 2013 0.75
59 Impact of mole mapping in the Italian health system. Dermatology 2013 0.75
60 Annular lichen planus on the mammary areola: an unusual localization. G Ital Dermatol Venereol 2016 0.75
61 Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study--the Italian multidisciplinary group on melanoma. Melanoma Res 2015 0.75
62 Management of small and intermediate congenital nevi: a nationwide survey in Italy. Dermatology 2013 0.75
63 Early activation of fibroblasts during PDT treatment in leg ulcers. G Ital Dermatol Venereol 2014 0.75
64 An Asymptomatic Plaque on the Chest: A Quiz. Acta Derm Venereol 2017 0.75
65 Animal-type melanoma: report of five cases with sentinel node biopsy and fluorescence in-situ hybridization analysis. Melanoma Res 2014 0.75
66 Erythema ab igne. Intern Emerg Med 2010 0.75
67 Melanoma survival: sex does matter, but we do not know how. Eur J Cancer Prev 2016 0.75